Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Thyroid tumors range from well-differentiated (papillary, follicular) with good prognosis to aggressive poorly differentiated (PDTC) and undifferentiated (UTC) types.
• PDTC and UTC are thought to arise de novo or progress from well-differentiated thyroid carcinomas (WDTC) through genetic and epigenetic changes.
• The molecular alterations driving PDTC and UTC progression are not fully understood.

Purpose of the Study:

• To review the molecular changes associated with aggressive thyroid cancers, specifically PDTC and UTC.
• To explore the relationship between molecular alterations in WDTC and their potential progression to more aggressive thyroid tumor types.
• To identify key genetic markers that differentiate tumor aggressiveness and aid in diagnosis.

Main Methods:

• Literature review of studies investigating molecular alterations in thyroid carcinomas.
• Analysis of genetic and epigenetic changes in well-differentiated, poorly differentiated, and undifferentiated thyroid tumors.
• Comparison of molecular marker prevalence across different thyroid cancer subtypes.

Main Results:

• Some PDTC and UTC tumors share molecular markers (e.g., BRAF, NRAS) with WDTC, supporting a progression model.
• P53 gene mutations are predominantly found in less differentiated and undifferentiated thyroid tumors, correlating with aggressive phenotypes.
• Thyroid-specific rearrangements (RET/PTC, PAX8/PPARγ) are infrequent in PDTC and UTC, suggesting they do not drive dedifferentiation.

Conclusions:

• Molecular profiling reveals distinct genetic landscapes for different thyroid cancer subtypes.
• Certain genetic alterations, like P53 mutations, are indicative of aggressive thyroid cancer progression.
• Understanding these molecular changes is crucial for diagnosing and potentially treating advanced thyroid malignancies.